Skip to content

Study · Systematic review · n = 300 · 2025

2 results

Impact of Semaglutide Administration on Weight Loss After Bariatric Surgery: A Meta-Analysis.

Jamialahamdi T, Mirhadi E, Almahmeed W, Virani S, Eid AH, Al-Rasadi K, Salehabadi S, Sahebkar A

Obesity surgery26 May 2025Cited by 2 (Europe PMC)

PMID40418526 (opens in a new tab)DOI10.1007/s11695-025-07848-y (opens in a new tab)PepBankPUB-40418526
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanSystematic reviewEfficacy outcome

    In patients with weight gain or inadequate weight loss after bariatric surgery, semaglutide produced a significant weight reduction in a meta-analysis of six studies.

    In plain wordsIn people who regained weight or lost too little after weight-loss surgery, semaglutide was linked to clear weight loss in a pooled analysis.

    Peptide
    Semaglutide
    Outcome
    DecreaseWeight reduction after semaglutide following bariatric surgery
    Study

    n = 300

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated

    Measurements

    WMD
    −15.73 NR
    six studies

    Source sentences

    Summary
    A total of six studies (300 participants) demonstrated significant weight reduction following semaglutide administration after bariatric surgery (WMD: - 15.730, 95% CI: - 22.140, - 9.320, p < 0.001).
    1 context sentence
    Summary · context
    Databases were searched for randomized controlled trials (RCTs), case-control, cohort and observational studies involving use of semaglutide in the intervention arm post-bariatric surgery.
  2. 02HumanSystematic reviewEfficacy outcome

    In the sensitivity analysis, the weight reduction with semaglutide after bariatric surgery remained robust.

    In plain wordsThe weight loss linked to semaglutide after weight-loss surgery held up in a check using different assumptions.

    Peptide
    Semaglutide
    Outcome
    DecreaseRobustness of weight reduction in sensitivity analysis
    Study

    n: not reported in source

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    This effect remained robust in sensitivity analysis.
    1 context sentence
    Summary · context
    Databases were searched for randomized controlled trials (RCTs), case-control, cohort and observational studies involving use of semaglutide in the intervention arm post-bariatric surgery.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.